These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32723380)

  • 41. NRF1 motif sequence-enriched genes involved in ER/PR -ve HER2 +ve breast cancer signaling pathways.
    Ramos J; Das J; Felty Q; Yoo C; Poppiti R; Murrell D; Foster PJ; Roy D
    Breast Cancer Res Treat; 2018 Nov; 172(2):469-485. PubMed ID: 30128822
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Estrogen receptor variants in normal human mammary tissue.
    Leygue ER; Watson PH; Murphy LC
    J Natl Cancer Inst; 1996 Mar; 88(5):284-90. PubMed ID: 8614007
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures.
    Kabos P; Finlay-Schultz J; Li C; Kline E; Finlayson C; Wisell J; Manuel CA; Edgerton SM; Harrell JC; Elias A; Sartorius CA
    Breast Cancer Res Treat; 2012 Sep; 135(2):415-32. PubMed ID: 22821401
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Indoor radon and lung cancer risk in connecticut and utah.
    Sandler DP; Weinberg CR; Shore DL; Archer VE; Stone MB; Lyon JL; Rothney-Kozlak L; Shepherd M; Stolwijk JA
    J Toxicol Environ Health A; 2006 Apr; 69(7):633-54. PubMed ID: 16608830
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers.
    Yau C; Fedele V; Roydasgupta R; Fridlyand J; Hubbard A; Gray JW; Chew K; Dairkee SH; Moore DH; Schittulli F; Tommasi S; Paradiso A; Albertson DG; Benz CC
    Breast Cancer Res; 2007; 9(5):R59. PubMed ID: 17850661
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FOXA1 Protein Expression in ER
    Cheng TD; Yao S; Omilian AR; Khoury T; Buas MF; Payne-Ondracek R; Sribenja S; Bshara W; Hong CC; Bandera EV; Davis W; Higgins MJ; Ambrosone CB
    Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):379-385. PubMed ID: 31871111
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer.
    Simigdala N; Gao Q; Pancholi S; Roberg-Larsen H; Zvelebil M; Ribas R; Folkerd E; Thompson A; Bhamra A; Dowsett M; Martin LA
    Breast Cancer Res; 2016 Jun; 18(1):58. PubMed ID: 27246191
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Network-based approach to identify prognosis-related genes in tamoxifen-treated patients with estrogen receptor-positive breast cancer.
    Wang Y; Gong X; Zhang Y
    Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34406386
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Residential radon and risk of lung cancer in an Italian alpine area.
    Pisa FE; Barbone F; Betta A; Bonomi M; Alessandrini B; Bovenzi M
    Arch Environ Health; 2001; 56(3):208-15. PubMed ID: 11480496
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk factors for lung cancer in Iowa women: implications for prevention.
    Neuberger JS; Mahnken JD; Mayo MS; Field RW
    Cancer Detect Prev; 2006; 30(2):158-67. PubMed ID: 16581199
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Case-control study of radon and lung cancer in New Jersey.
    Wilcox HB; Al-Zoughool M; Garner MJ; Jiang H; Klotz JB; Krewski D; Nicholson WJ; Schoenberg JB; Villeneuve PJ; Zielinski JM
    Radiat Prot Dosimetry; 2008; 128(2):169-79. PubMed ID: 17611199
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dosimetric challenges for residential radon epidemiology.
    Steck DJ; Field RW
    J Toxicol Environ Health A; 2006 Apr; 69(7):655-64. PubMed ID: 16608831
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A risk-associated Active transcriptome phenotype expressed by histologically normal human breast tissue and linked to a pro-tumorigenic adipocyte population.
    Kang T; Yau C; Wong CK; Sanborn JZ; Newton Y; Vaske C; Benz SC; Krings G; Camarda R; Henry JE; Stuart J; Powell M; Benz CC
    Breast Cancer Res; 2020 Jul; 22(1):81. PubMed ID: 32736587
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of a prognostic LncRNA signature for ER-positive, ER-negative and triple-negative breast cancers.
    Liu D
    Breast Cancer Res Treat; 2020 Aug; 183(1):95-105. PubMed ID: 32601968
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factors affecting use of CR-39 surface monitor technology to estimate past exposure to indoor radon.
    Mahaffey JA; Parkhurst MA; Hui TE; Brownson RC; Alavanja MC
    J Expo Anal Environ Epidemiol; 1996; 6(4):425-37. PubMed ID: 9087863
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Residential Radon Exposure and Skin Cancer Incidence in a Prospective Danish Cohort.
    Bräuner EV; Loft S; Sørensen M; Jensen A; Andersen CE; Ulbak K; Hertel O; Pedersen C; Tjønneland A; Krüger Kjær S; Raaschou-Nielsen O
    PLoS One; 2015; 10(8):e0135642. PubMed ID: 26274607
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Parity-related molecular signatures and breast cancer subtypes by estrogen receptor status.
    Rotunno M; Sun X; Figueroa J; Sherman ME; Garcia-Closas M; Meltzer P; Williams T; Schneider SS; Jerry DJ; Yang XR; Troester MA
    Breast Cancer Res; 2014 Jul; 16(4):R74. PubMed ID: 25005139
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nonlinear dose-response relationship between radon exposure and the risk of lung cancer: evidence from a meta-analysis of published observational studies.
    Duan P; Quan C; Hu C; Zhang J; Xie F; Hu X; Yu Z; Gao B; Liu Z; Zheng H; Liu C; Wang C; Yu T; Qi S; Fu W; Kourouma A; Yang K
    Eur J Cancer Prev; 2015 Jul; 24(4):267-77. PubMed ID: 25117725
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype.
    Hefti MM; Hu R; Knoblauch NW; Collins LC; Haibe-Kains B; Tamimi RM; Beck AH
    Breast Cancer Res; 2013; 15(4):R68. PubMed ID: 23971947
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transcriptome- and proteome-oriented identification of dysregulated eIF4G, STAT3, and Hippo pathways altered by PIK3CA
    Cheng F; Zhao J; Hanker AB; Brewer MR; Arteaga CL; Zhao Z
    Breast Cancer Res Treat; 2016 Dec; 160(3):457-474. PubMed ID: 27771839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.